SCHEMBL2978705

SCHEMBL2978705

O=C(O)[C@H](Cc1c[nH]cn1)NCCc1cc(O)ccc1O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CPB2 Q96IY4 6/20 0.36
▸ CPB1 P15086 1/20 0.36
▸ EGFR P00533 3/20 0.36
▸ LCK P06239 2/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ ALDH1A1 P00352 3/20 0.34
▸ TP53 P04637 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ ALOX12 P18054 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ CKS1B P61024 1/20 0.34
▸ SKP2 Q13309 1/20 0.34
▸ HIF1A Q16665 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ TDP1 Q9NUW8 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2982881 0.91 MEN1 (0.40) CPB2CPB1MEN1KMT2A
SCHEMBL2980934 0.86 CPB2 (0.38) CPB2CPB1MEN1KMT2A
SCHEMBL2985204 0.82 CNR1 (0.34) EGFRALDH1A1TP53CYP1A2CYP3A4
SCHEMBL2974157 0.81 CPB2 (0.38) CPB2CPB1MEN1KMT2AALDH1A1
SCHEMBL1667207 0.79 GGT1 (0.42) CPB2CPB1MEN1KMT2ACYP1A2
SCHEMBL1667210 0.79 GGT1 (0.42) CPB2CPB1MEN1KMT2ACYP1A2
SCHEMBL2976460 0.78 NAALAD2 (0.48) EGFRLCKMEN1KMT2AALDH1A1
SCHEMBL2985265 0.78 EGFR (0.43) EGFRLCKMEN1KMT2AALDH1A1
SCHEMBL2978710 0.78 CYP3A4 (0.49) ALDH1A1CYP1A2CYP3A4CYP2C19HIF1A
SCHEMBL2984586 0.77 ITGA4 (0.45) EGFRLCKKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090074691-A1 Topical Delivery System for Antiaging and Skin Whitening Agents BIODERM RESEARCH (US) 2009-03-19 — — US claimed
US-7777073-B2 Topical delivery system for antiaging and skin whitening agents BIODERM RESEARCH (US) 2010-08-17 — — US disclosed
US-20090074691-A1 Topical Delivery System for Antiaging and Skin Whitening Agents BIODERM RESEARCH (US) 2009-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090074691-A1 Topical Delivery System for Antiaging and Skin Whitening Agents TYR, MMP17, MMP1 CPB2 1799/4885CPB1 1601/4885EGFR 357/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback